82P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pacira Biosciences Inc

Watchlist Manager

Watchlist

Price: 23.6 EUR 1.72%

Market Cap: €2B

P	Pacira Biosciences Inc SWB:82P	US
	National Retail Properties Inc NYSE:NNN	US
I	IPD Group Ltd ASX:IPG	AU
	Premia Finance SpA Societa di Mediazione Creditizia F:81U	IT
D	Daiichi Life Group Inc XMUN:QHH	JP
E	Equifax Inc XMUN:EFX	US
	Nintendo Co Ltd LSE:0K85	JP
J	JD.com Inc F:013C	CN
J	Jones Lang LaSalle Inc LSE:0JPB	US
R	Red Robin Gourmet Burgers Inc SWB:RRN	US
F	Ford Motor Co SWB:FMC1	US
K	Kinder Morgan Inc XETRA:2KD	US
S	Scor SE SWB:SDRC	FR
M	Mattel Inc XHAM:MTT	US
M	Medtronic PLC F:2M6	IE
S	Sumitomo Corp SWB:SUMA	JP
S	Synopsys Inc XMUN:SYP	US

Profitability Summary

Pacira Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

76%

Gross Margin is Increasing

69% > 79%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

10% > 5%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-1% > 2%

Exceptional Free Cash Flow Margin

24%

Strong 3Y Average Free Cash Flow Margin

21%

Free Cash Flow Margin is Increasing

19% > 24%

Low ROE

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.